🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 17 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
06/08/2008 20,10 20,70 20,10 20,70 +2,48% 2,99% 13.280
05/08/2008 21,70 21,70 20,10 20,20 -4,27% 7,37% 14.320
04/08/2008 20,90 22,00 20,80 21,10 -1,40% 5,74% 10.880
01/08/2008 21,10 22,00 21,10 21,40 +1,42% 4,27% 4.310
31/07/2008 21,20 22,00 21,00 21,10 -3,21% 4,72% 2.180
30/07/2008 20,80 22,00 20,60 21,80 +3,81% 6,73% 6.030
29/07/2008 21,60 21,60 20,10 21,00 -4,55% 6,94% 14.760
28/07/2008 23,30 23,30 21,80 22,00 -4,76% 6,44% 3.490
25/07/2008 23,10 23,40 22,60 23,10 +0,00% 3,46% 2.130
24/07/2008 23,80 24,20 22,30 23,10 -4,55% 7,98% 4.810
23/07/2008 23,50 24,20 23,50 24,20 +2,11% 2,98% 2.320
22/07/2008 23,00 23,90 22,70 23,70 +2,60% 5,22% 2.890
21/07/2008 22,20 23,10 22,20 23,10 +7,44% 4,05% 6.220
18/07/2008 22,20 22,30 21,50 21,50 -3,15% 3,60% 3.960
17/07/2008 23,10 23,10 21,00 22,20 -2,20% 9,09% 8.470
16/07/2008 21,30 22,70 21,00 22,70 +5,09% 7,98% 4.880
15/07/2008 22,20 22,22 20,10 21,60 -5,68% 9,55% 18.120
14/07/2008 24,40 24,40 22,00 22,90 -2,55% 9,84% 9.130
11/07/2008 24,30 26,00 22,29 23,50 -4,08% 15,27% 16.310
10/07/2008 24,40 25,90 23,70 24,50 +0,00% 9,02% 10.780
09/07/2008 24,50 25,50 24,00 24,50 -2,00% 6,12% 8.470
08/07/2008 26,00 26,10 23,80 25,00 -3,47% 8,85% 12.000
07/07/2008 24,40 27,30 24,10 25,90 +8,82% 13,11% 18.810
03/07/2008 25,80 27,20 23,30 23,80 -7,75% 15,12% 7.390
02/07/2008 25,70 28,20 25,60 25,80 +1,98% 10,12% 16.920
01/07/2008 25,00 26,60 25,00 25,30 +1,61% 6,40% 15.790
30/06/2008 26,20 27,20 24,40 24,90 -2,73% 10,69% 17.200
27/06/2008 24,20 27,30 23,20 25,60 +5,79% 16,94% 366.040
26/06/2008 23,30 25,50 22,00 24,20 +1,68% 15,02% 30.520
25/06/2008 23,50 24,50 23,40 23,80 +0,42% 4,68% 4.180